Patents

U.S. patent gives Chromatin rights to construct mini-chromosomes in plants and animal cells

Published in Medical Device Business Week, February 28th, 2007

Chromatin, Inc., a leader in the design, delivery and use of mini-chromosomes, announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,119,250 entitled "Plant centromere compositions."

This landmark patent permits construction of mini-chromosomes as vectors for plant and animal cells and includes techniques for creating transgenic plants using engineered mini-chromosomes. Importantly, this patent is not specific to a particular plant species, but instead provides Chromatin with exclusive rights to use mini-chromosome technology in all plants.

The issued patent covers technology developed by doctors Daphne Preuss,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Device Business Week

Source: Medical Device Business Week (2007-02-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry